The South African Health Products Regulatory Authority has authorised an injection containing the antiretroviral cabotegravir for use to prevent HIV infection, according to drugmaker ViiV Healthcare. Laura Lopez Gonzalez reports.
As we look at the year ahead, urgent work remains to build on past successes and to bring the HIV epidemic sustainably under control. Amongst others, we need to address persistent stigma and discrimination, as well as the structural and social factors that put women and girls at increased risk of HIV infection, argues Rachel Toku-Appiah.
HIV prevention pills are becoming more widely available in South Africa and the country is set to soon start piloting the use of an HIV prevention injection. But merely having these tools available in clinics and other places does not mean people will use them. Thabo Molelekwa asked several experts what behaviour change communications should look like in this new era of HIV prevention.
Telling a child that he or she is living with HIV is not easy. Biénne Huisman spoke to a father and some doctors on how one approaches the issue.
On December 12, Ntimbwe Munongo Mpamba will celebrate his fortieth birthday with chocolate cake in Northgate, Johannesburg. He was born with HIV but only became aware of his HIV status many years later. Biénne Huisman spoke to him about living with HIV, his early years when his mother fed him medicine disguised as sweets, and now, living openly as an HIV awareness champion.
The theme for this year’s World AIDS Day is “Equalise and Integrate to End AIDS”. One aspect in which more equality is needed is between the quality of HIV testing services and aiming to test as many people as possible, argues René Sparks.
COVID-19 has pushed back our progress on tuberculosis, but we can claw back our gains when we work collaboratively and efficiently, writes Kelvin Vollenhoven and Neetha Morar.
Tuberculosis (TB) can be resistant to treatment with several different drugs. Tests that identify which drugs someone’s TB is resistant to are critical to ensuring that people are not treated with drugs that don’t work for them, especially given the significant side effects associated with some of the drugs. Elri Voigt assesses the state of play in testing for TB drug resistance and the promise of exciting new technologies, such as whole genome sequencing.
KwaZulu-Natal clinics are outperforming facilities monitored in other provinces on various indicators and health services in the province have improved year-on-year, but some marginalised groups continue to have a hard time accessing healthcare services. This is according to the latest provincial report from community-led monitoring project Ritshidze. Nthusang Lefafa spoke to several NGOs about the findings and asked the province’s health department for their response.
South Africa is expected to begin piloting the HIV prevention injection early next year as one of several projects that experts hope will reveal the answers to some of the biggest questions about the future of the shot – who will deliver the injection, where, and how to sell people on the idea that just six shots a year could protect them from HIV. Laura Lopez Gonzalez reports.
As a rebellious teenager growing up in the British town of Harpenden, Professor Helen Rees would sneak out to attend anti-apartheid talks. Today, she is a renowned scientist and chair of South Africa’s medicines regulator. Biénne Huisman chatted to Rees about her career, prioritising women’s reproductive health, and her role at the South African Health Products Regulatory Authority.
According to some estimates, over a third of tuberculosis (TB) patients have high levels of psychological distress and a quarter have an alcohol use disorder. Following an eye-opening project in KwaZulu-Natal, Atlantic Institute Tekano Fellow Amanda Fononda argues that a diagnosis of an illness (such as TB) should be accompanied by mental health screening for treatment readiness, adherence, and overall well-being.